Manas Jaiswal of manasjaiswal.com has a buy call on Dr.
Reddy's Laboratories Ltd.
with a target price of Rs 3000.
The current market price of Dr.
Reddy's Laboratories Ltd.
is Rs 2930.
Time period given by the analyst is Intra Day when Dr.
Reddy's Laboratories Ltd.
price can reach the defined target.
Manas Jaiswal recommended to keep stoploss at Rs 2885.
Dr.
Reddy's Laboratories Ltd., incorporated in 1984, has a market cap of Rs 48560.17 crore.Dr.
Reddy's Laboratories Ltd.
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9246.80 Crore to Sales Value (98.79 % of Total Sales), Licence Fees which contributed Rs 55.80 Crore to Sales Value (0.59 % of Total Sales), Spent Chemicals which contributed Rs 29.70 Crore to Sales Value (0.31 % of Total Sales), Scrap which contributed Rs 16.00 Crore to Sales Value (0.17 % of Total Sales) and Other Operating Revenue which contributed Rs 11.00 Crore to Sales Value (0.11 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 3786.10 Crore, up 2.70 % from last quarter Sales of Rs 3686.60 Crore and down -.52 % from last year same quarter Sales of Rs 3806.00 Crore Company has reported net profit after tax of Rs 491.40 Crore in latest quarter.
The companys top management includes Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Allan Oberman, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Prasad R Menon, Mr.Sridar Iyengar, Ms.Kalpana Morparia, Ms.Shikha Sanjaya Sharma.
Company has S R Batliboi Associates LLP as its auditoRs As on 31-03-2019, the company has a total of 166,065,948 shares outstanding.